IOL Chemicals and Pharmaceuticals: Submission of Financial Results
IOL Chemicals and Pharmaceuticals (IOLCP) filed a disclosure titled "Submission of Financial Results". The company is valued at about ₹5,215 crore.
What happened
IOL Chemicals and Pharmaceuticals (IOLCP) filed a disclosure with the exchanges on 30 October 2026 at 05:59 PM titled "Submission of Financial Results".
Company snapshot
IOL Chemicals and Pharmaceuticals is a small-cap company, with a market value of about ₹5,215 crore.
The stock last traded at ₹177.7, against a 52-week range of ₹67.19–₹224 (20.7% below the high).
Before this filing the shares had moved −11.5% over the month and +22.6% over three months. Average daily turnover over the last 20 sessions was about ₹55.16 crore.
Promoters held 62.28% at the end of Q1 FY27, up 4.80% points from the previous quarter. Foreign institutions owned 4.87% and domestic institutions 0.43%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 552 | 33.9 | 1.16 |
| Q2 FY26 | 568 | 30 | 1.02 |
| Q3 FY26 | 580 | 20.6 | 0.7 |
| Q4 FY26 | 619 | 53.2 | 1.81 |
| Q1 FY27 | 756 | 64.4 | 2.2 |
What history shows
BCEIE's records show 3 previous results filings from the company since May 2026.
After those filings, the stock fell 2.2% on average the next trading day and was down 3.9% on average after five days (2 filings with price data).
Market-wide, 10,043 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 10 Aug 2026 | Outcome Of The Board Meeting And Submission Of Unaudited Financial… | −2.2% | −3.9% |
| 10 Aug 2026 | Board Meeting Outcome for Outcome Of The Board Meeting And… | −2.2% | −3.9% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 30 October 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.